Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL Amyloidosis

Clin Lymphoma Myeloma Leuk. 2021 Jun;21(6):425-426. doi: 10.1016/j.clml.2021.01.021. Epub 2021 Feb 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Combined Modality Therapy
  • Disease Management
  • Humans
  • Immunoglobulin Light-chain Amyloidosis / diagnosis*
  • Immunoglobulin Light-chain Amyloidosis / etiology
  • Immunoglobulin Light-chain Amyloidosis / mortality
  • Immunoglobulin Light-chain Amyloidosis / therapy*
  • Prognosis
  • Treatment Outcome

Substances

  • Biomarkers